101 related articles for article (PubMed ID: 9925253)
21. In vitro efficacy of a novel chemoradiopotentiator--taxoltere metro.
Yang LX; Wang HJ; Holton RA
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):159-63. PubMed ID: 10656388
[TBL] [Abstract][Full Text] [Related]
22. Effects of docetaxel in combination with radiation on human head and neck cancer cells (ZMK-1) and cervical squamous cell carcinoma cells (CaSki ).
Pradier O; Rave-Fränk M; Lehmann J; Lücke E; Boghun O; Hess CF; Schmidberger H
Int J Cancer; 2001 Mar; 91(6):840-5. PubMed ID: 11275989
[TBL] [Abstract][Full Text] [Related]
23. Radiation survival of two human cervical carcinoma cell lines after multifraction irradiation.
Werts ED; Burholt DR; Paljug WR; Polizotto SL; Yann VM
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):941-50. PubMed ID: 8751403
[TBL] [Abstract][Full Text] [Related]
24. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death.
Blagosklonny MV; Giannakakou P; el-Deiry WS; Kingston DG; Higgs PI; Neckers L; Fojo T
Cancer Res; 1997 Jan; 57(1):130-5. PubMed ID: 8988053
[TBL] [Abstract][Full Text] [Related]
25. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
Leonard CE; Chan DC; Chou TC; Kumar R; Bunn PA
Cancer Res; 1996 Nov; 56(22):5198-204. PubMed ID: 8912857
[TBL] [Abstract][Full Text] [Related]
26. Inhibiting CD146 by its Monoclonal Antibody AA98 Improves Radiosensitivity of Cervical Cancer Cells.
Cheng H
Med Sci Monit; 2016 Sep; 22():3328-33. PubMed ID: 27647179
[TBL] [Abstract][Full Text] [Related]
27. Paclitaxel and simultaneous radiation in locally advanced stage IIIA/B non-small cell lung cancer: a clinical phase I study.
Vogt HG; Kolotas C; Martin T; Schneider LV; Goes-Schmieder R; Mitrou PS; Diergarten K; Kober B; Zamboglou N
Semin Oncol; 1996 Dec; 23(6 Suppl 16):120-3. PubMed ID: 9007138
[TBL] [Abstract][Full Text] [Related]
28. Cellular response to chemotherapy and radiation in cervical cancer.
Saxena A; Yashar C; Taylor DD; Gercel-Taylor C
Am J Obstet Gynecol; 2005 May; 192(5):1399-403. PubMed ID: 15902120
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation.
Gupta N; Hu LJ; Deen DF
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):885-95. PubMed ID: 9128966
[TBL] [Abstract][Full Text] [Related]
30. Sensitization of cervical carcinoma cells to paclitaxel by an IPP5 active mutant.
Zeng QY; Huang Y; Zeng LJ; Huang M; Huang YQ; Zhu QF
Asian Pac J Cancer Prev; 2014; 15(19):8337-43. PubMed ID: 25339026
[TBL] [Abstract][Full Text] [Related]
31. Insulin can modulate MCF-7 cell response to paclitaxel.
Miglietta A; Panno ML; Bozzo F; Gabriel L; Bocca C
Cancer Lett; 2004 Jun; 209(2):139-45. PubMed ID: 15159015
[TBL] [Abstract][Full Text] [Related]
32. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of Raf-1 kinase is associated with paclitaxel resistance in human breast cancer MCF-7/Adr cells.
Lee M; Koh WS; Han SS
Cancer Lett; 2003 Apr; 193(1):57-64. PubMed ID: 12691824
[TBL] [Abstract][Full Text] [Related]
34. Enhanced therapeutic effects of doxorubicin and paclitaxel in combination with liposome-entrapped ends-modified raf antisense oligonucleotide against human prostate, lung and breast tumor models.
Mewani RR; Tang W; Rahman A; Dritschilo A; Ahmad I; Kasid UN; Gokhale PC
Int J Oncol; 2004 May; 24(5):1181-8. PubMed ID: 15067340
[TBL] [Abstract][Full Text] [Related]
35. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway.
Blagosklonny MV; Schulte T; Nguyen P; Trepel J; Neckers LM
Cancer Res; 1996 Apr; 56(8):1851-4. PubMed ID: 8620503
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel: a radiation sensitizer of human cervical cancer cells.
Rodriguez M; Sevin BU; Perras J; Nguyen HN; Pham C; Steren AJ; Koechli OR; Averette HE
Gynecol Oncol; 1995 May; 57(2):165-9. PubMed ID: 7729728
[TBL] [Abstract][Full Text] [Related]
37. Potentiation of the radiation effect with genistein in cervical cancer cells.
Yashar CM; Spanos WJ; Taylor DD; Gercel-Taylor C
Gynecol Oncol; 2005 Oct; 99(1):199-205. PubMed ID: 16083949
[TBL] [Abstract][Full Text] [Related]
38. Growth inhibitory effects and radiosensitization induced by fatty aromatic acids on human cervical cancer cells.
Ferrandina G; Filippini P; Ferlini C; Maggiano N; Stoler AB; Fruscella E; Mozzetti S; Mancuso S; Freedman RS; Scambia G; Ranelletti FO
Oncol Res; 2000; 12(9-10):429-40. PubMed ID: 11697821
[TBL] [Abstract][Full Text] [Related]
39. Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinoma.
Tang J; Tang Y; Yang J; Huang S
Gynecol Oncol; 2012 May; 125(2):297-302. PubMed ID: 22307061
[TBL] [Abstract][Full Text] [Related]
40. Bcl-xL is phosphorylated in malignant cells following microtubule disruption.
Poruchynsky MS; Wang EE; Rudin CM; Blagosklonny MV; Fojo T
Cancer Res; 1998 Aug; 58(15):3331-8. PubMed ID: 9699663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
